Precision repurposing of clinically characterized molecules targeting dengue virus RNA-dependent RNA polymerase: an in silico identification and in vitro validation.
Proanthocyanidin is identified as a promising RdRp-targeting antiviral candidate and the value of integrating computational and experimental approaches for dengue drug discovery is demonstrated, demonstrating the value of integrating computational and experimental approaches for dengue drug discovery.